1. Home
  2. CYTK vs ZETA Comparison

CYTK vs ZETA Comparison

Compare CYTK & ZETA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • ZETA
  • Stock Information
  • Founded
  • CYTK 1997
  • ZETA 2007
  • Country
  • CYTK United States
  • ZETA United States
  • Employees
  • CYTK N/A
  • ZETA N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • ZETA EDP Services
  • Sector
  • CYTK Health Care
  • ZETA Technology
  • Exchange
  • CYTK Nasdaq
  • ZETA Nasdaq
  • Market Cap
  • CYTK 5.0B
  • ZETA 5.0B
  • IPO Year
  • CYTK 2004
  • ZETA 2021
  • Fundamental
  • Price
  • CYTK $50.26
  • ZETA $20.73
  • Analyst Decision
  • CYTK Strong Buy
  • ZETA Strong Buy
  • Analyst Count
  • CYTK 17
  • ZETA 15
  • Target Price
  • CYTK $82.00
  • ZETA $35.43
  • AVG Volume (30 Days)
  • CYTK 1.9M
  • ZETA 5.5M
  • Earning Date
  • CYTK 02-27-2025
  • ZETA 02-25-2025
  • Dividend Yield
  • CYTK N/A
  • ZETA N/A
  • EPS Growth
  • CYTK N/A
  • ZETA N/A
  • EPS
  • CYTK N/A
  • ZETA N/A
  • Revenue
  • CYTK $3,219,000.00
  • ZETA $901,401,000.00
  • Revenue This Year
  • CYTK N/A
  • ZETA $38.19
  • Revenue Next Year
  • CYTK $754.18
  • ZETA $22.74
  • P/E Ratio
  • CYTK N/A
  • ZETA N/A
  • Revenue Growth
  • CYTK N/A
  • ZETA 29.97
  • 52 Week Low
  • CYTK $40.53
  • ZETA $9.97
  • 52 Week High
  • CYTK $81.36
  • ZETA $38.20
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 58.40
  • ZETA 49.90
  • Support Level
  • CYTK $45.05
  • ZETA $19.97
  • Resistance Level
  • CYTK $48.30
  • ZETA $26.60
  • Average True Range (ATR)
  • CYTK 2.80
  • ZETA 1.59
  • MACD
  • CYTK 0.61
  • ZETA 0.20
  • Stochastic Oscillator
  • CYTK 86.80
  • ZETA 37.08

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ZETA Zeta Global Holdings Corp.

Zeta Global Holdings Corp is an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software. It serves enterprise customers across multiple industries, including financial services, insurance, telecommunications, automotive, travel and hospitality, and retail. Its Zeta Marketing Platform, or ZMP, is an omnichannel marketing platform with identity data at its core. The ZMP can analyze billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry's opted-in data set for omnichannel marketing.

Share on Social Networks: